Tag: Plant-Based Drugs

Roquette and Thermo Fisher entered into distribution agreement

Roquette, a global leader in innovative plant-based pharmaceutical ingredients, and Thermo Fisher Scientific, are announcing a distribution agreement for the Roquette portfolio of pharma ingredients.

Axim Biotechnologies receives Dutch GMP for cannabinoid medicines production

AXIM Biotechnologies announced that it has received a manufacturing license from the Dutch Ministry of Health, Welfare and Sports for the production of the company’s pharmaceutical products.

Noramco boosts its cannabinoid production capabilities

Noramco, a leader in controlled substances and cannabinoids, is adding commercial-scale capacity of dronabinol (THC) at its Athens, Georgia (USA) facility.

Yom Chai enters into a strategic partnership with Kaneh-B

medicinal cannabis
Yom Chai announced that it has entered into a strategic partnership with Kaneh-B to co-found the development and clinical validation of a range of cannabis based ADHD products.

CFU scientists develop phytobiotics from Crimean wild plants

Phytobiotics, a biologically active substance isolated from plants, can become a real alternative to antibiotics, improve the immunity of patients and fight hospital infections

AMRI will manufacture cannabinoid-based API for Nemus Bioscience

Nemus Bioscience announced an agreement with AMRI for the development and manufacture of Nemus’ proprietary cannabinoid-based active pharmaceutical ingredients (API).

EEC continues to improve EAEU common market of medicines

The Board approved the passport and procedure for maintaining the reference book of international nonproprietary names. The decision provides for its inclusion in the EAEU unified regulatory and reference information system.

Indian scientists developed an Ayurvedic dengue drug

The Central Council for Research in Ayurvedic Sciences (CCRAS, India) and regional research centre in Karnataka’s Belgaum (India) have started conducting pilot studies for the medicine that have been proved clinically safe.

Tilray set up a strategic alliance with a leading Canadian pharma company

medicinal cannabis
Tilray, a licensed producer of medical cannabis, signed a binding letter of intent to be the collaborator of a major pharma company to accelerate innovation and increase availability of high quality medical cannabis products.

Russian scientists are developing phytobiotics for livestock farming

The scientists at the Kemerovo State Agricultural Institute are developing phytobiotics from Siberian herbs; it is expected that the drugs would be able to replace similar imported additives and antibiotics

AXIM Biotech uses cGMP methods for its production of cannabinoid APIs

medicinal cannabis
AXIM Biotechnologies announced the successful execution of proprietary cGMP methods to extract and microencapsulate cannabinoid molecules for a variety of pharmaceutical delivery formats from cGMP-produced medicinal cannabis.

Bionorica marks the 20th anniversary of its activities in Russia

Bionorica held a press conference in Moscow to mark the 20th anniversary of its activities in Russia.

Association of Manufacturers of Plant-Based Medicinal Products is established in Russia

The Association of Manufacturers and Consumers of Plant-Based Medicinal Products, a new public organization, has been registered by the Russian Ministry of Justice.